Skip to content
★ Sign in to follow
JE

John E. Elicker

Executive
Bristol Myers Squibb Co
Total declarations
146
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€4.9M

Latest filing published 12 Mar 2020 for Bristol Myers Squibb Co, €19k.

Filing timeline

BuySale
John E. Elicker

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

John E. Elicker: trading record in brief

John E. Elicker discloses dealings in Bristol Myers Squibb Co to SEC (Form 4). The record holds 146 filings, for trades running from 26 October 2012 to 10 March 2020.

Every open-market trade on record is a sale: 14 sales worth €4.9M. Outside the open market, there are 48 share grants and 52 option exercises. So far in 2020, the count stands at no purchases and 1 sale.

On 12 March 2020 came the latest disclosure, a share grant for €19k in Bristol Myers Squibb Co. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John E. Elicker

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations145 total

25 of 145 declarations